Apostolakis Sotirios, Kapetanakis Stylianos
Department of Neurosurgery, KAT General Hospital of Attica, Athens, Greece.
Spine Department and Deformities, Interbalkan European Medical Center, Thessaloniki, Greece.
Spine Surg Relat Res. 2023 Jul 6;8(1):10-21. doi: 10.22603/ssrr.2023-0079. eCollection 2024 Jan 27.
The emergence of novel minimally invasive techniques has opened new horizons for the management of degenerative diseases of the spine. Platelet-rich plasma (PRP) has gained considerable attention through its applications in various pathologies. In the present review, an overview of the science behind the application of PRP is provided, ultimately focusing on the clinical trials that may render it a useful tool in the hands of spine surgeons in the future.
A review of the available literature is conducted, focusing on its existing clinical and experimental applications with a particular interest in the degenerative diseases of the spine.
In terms of the degenerative diseases of the spine, initial studies suggest that it is a safe and effective method that could change the practice of spinal cord medicine in the years to come. The available studies demonstrate that besides being minimally invasive, causing less discomfort than that of surgery, it provides longer lasting improvement than standard pharmaceutical interventions.
PRP is an emerging and promising biodrug for the treatment of patients with spinal pain. PRP has demonstrated some promising qualities; however, careful consideration of its indications of use and strict protocols of application need to be established before widespread clinical induction.
新型微创技术的出现为脊柱退行性疾病的治疗开辟了新视野。富血小板血浆(PRP)因其在各种病理状况中的应用而备受关注。在本综述中,提供了PRP应用背后的科学概述,最终聚焦于那些可能使其在未来成为脊柱外科医生手中有用工具的临床试验。
对现有文献进行综述,重点关注其现有的临床和实验应用,尤其关注脊柱退行性疾病。
就脊柱退行性疾病而言,初步研究表明它是一种安全有效的方法,可能在未来改变脊髓医学的实践。现有研究表明,它除了微创、比手术引起的不适更少外,还比标准药物干预提供更持久的改善。
PRP是一种用于治疗脊柱疼痛患者的新兴且有前景的生物药物。PRP已展现出一些有前景的特性;然而,在广泛临床应用之前,需要仔细考虑其使用指征并建立严格的应用方案。